Cargando…
Discovery and Validation of Potential Serum Biomarkers with Pro-Inflammatory and DNA Damage Activities in Ulcerative Colitis: A Comprehensive Untargeted Metabolomic Study
Ulcerative colitis is a type of non-specific inflammatory bowel disease with unclear etiology. It is considered a progressive disease with risks of bowel motility disorders, anorectal dysfunction, and even colorectal cancer. Commonly used diagnostic markers have poor specificity and cannot predict t...
Autores principales: | Li, Mingxiao, Zhang, Rui, Xin, Mingjie, Xu, Yi, Liu, Shijia, Yu, Boyang, Zhang, Boli, Liu, Jihua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9609580/ https://www.ncbi.nlm.nih.gov/pubmed/36295899 http://dx.doi.org/10.3390/metabo12100997 |
Ejemplares similares
-
Protective Effect of Ethyl Rosmarinate against Ulcerative Colitis in Mice Based on Untargeted Metabolomics
por: Zhou, Baisong, et al.
Publicado: (2022) -
Untargeted serum metabolomics reveals specific metabolite abnormalities in patients with Crohn's disease
por: Liu, Huanhuan, et al.
Publicado: (2022) -
Discovery of Pancreatic Adenocarcinoma Biomarkers by Untargeted Metabolomics
por: Martín-Blázquez, Ariadna, et al.
Publicado: (2020) -
Metabolite discovery through global annotation of untargeted metabolomics data
por: Chen, Li, et al.
Publicado: (2021) -
Evaluation of Untargeted Metabolomic Strategy for the Discovery of Biomarker of Breast Cancer
por: Ruan, Xujun, et al.
Publicado: (2022)